Evidence map›Paper›PMID 33404280›Full record

ArticleAutophagy2021

Crocetin promotes clearance of amyloid-β by inducing autophagy via the STK11/LKB1-mediated AMPK pathway.

Abubakar Wani, Sweilem B Al Rihani, Ankita Sharma, Brenna Weadick, Rajgopal Govindarajan, Sameer U Khan, Parduman R Sharma, Ashish Dogra, Utpal Nandi, Chilakala N Reddy and 6 more

Open access · greenAbstract read
In one paragraph

Article in Autophagy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 96 papers.

0numbers the graph read from it
0cells of the map it votes in
96citing papers in PubMed
9.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

96 citing papers in PubMed, 165 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

36 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 2 countries.

Abubakar WaniDivision of PK-PD-Toxicology and Formulation, CSIR-Indian Institute of Integrative Medicine, Jammu, India.
Sweilem B Al RihaniDepartment of Drug Discovery and Development, Harrison School of Pharmacy, Auburn University, Auburn, Alabama, USA.ORCID 0000-0003-2415-4664
Ankita SharmaDivision of PK-PD-Toxicology and Formulation, CSIR-Indian Institute of Integrative Medicine, Jammu, India.
Brenna WeadickDivision of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, Ohio State University, Columbus, Ohio, USA.
Rajgopal GovindarajanDivision of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, Ohio State University, Columbus, Ohio, USA.
Sameer U KhanDivision of PK-PD-Toxicology and Formulation, CSIR-Indian Institute of Integrative Medicine, Jammu, India.
Parduman R SharmaAcademy of Scientific and Innovative Research (Acsir), Ghaziabad, India.
Ashish DograDivision of PK-PD-Toxicology and Formulation, CSIR-Indian Institute of Integrative Medicine, Jammu, India.
Utpal NandiDivision of PK-PD-Toxicology and Formulation, CSIR-Indian Institute of Integrative Medicine, Jammu, India.ORCID 0000-0002-7868-0240
Chilakala N ReddyPreformulation Laboratory, PK-PD Toxicology and Formulation Division, CSIR- Indian Institute of Integrative Medicine, Jammu, India.
Sonali S BharatePreformulation Laboratory, PK-PD Toxicology and Formulation Division, CSIR- Indian Institute of Integrative Medicine, Jammu, India.
Gurdarshan SinghDivision of PK-PD-Toxicology and Formulation, CSIR-Indian Institute of Integrative Medicine, Jammu, India.
Sandip B BharateAcademy of Scientific and Innovative Research (Acsir), Ghaziabad, India.
Ram A VishwakarmaAcademy of Scientific and Innovative Research (Acsir), Ghaziabad, India.
Amal KaddoumiDepartment of Drug Discovery and Development, Harrison School of Pharmacy, Auburn University, Auburn, Alabama, USA.ORCID 0000-0001-9792-7766
Ajay KumarDivision of PK-PD-Toxicology and Formulation, CSIR-Indian Institute of Integrative Medicine, Jammu, India.ORCID 0000-0002-3889-3049
Indian Institute of Integrative Medicine · INAuburn University · USNarsee Monjee Institute of Management Studies · INThe Ohio State University · USWashington University in St. Louis · US

Funding

Targeting cerebrovascular endothelial cells as a therapeutic approach for amyloid pathogenesisR15NS091934 · NINDS · UNIVERSITY OF LOUISIANA AT MONROE · PI KHALIL KADDOUMI, AMAL F · 2015 to 2015
$420k
NINDS NIH HHS R15 NS091934
6 · The paper itself

Abstract

Alzheimer disease (AD) is usually accompanied by two prominent pathological features, cerebral accumulation of amyloid-β (Aβ) plaques and presence of MAPT/tau neurofibrillary tangles. Dysregulated clearance of Aβ largely contributes to its accumulation and plaque formation in the brain. Macroautophagy/autophagy is a lysosomal degradative process, which plays an important role in the clearance of Aβ. Failure of autophagic clearance of Aβ is currently acknowledged as a contributing factor to increased accumulation of Aβ in AD brains. In this study, we have identified crocetin, a pharmacologically active constituent from the flower stigmas of

Indexed as

AMP-Activated Protein KinasesAmyloid beta-PeptidesAnimalsAutophagyCarotenoidsCell LineFemaleMaleMAP Kinase Signaling SystemMiceMice, Inbred C57BLMicrogliaVitamin AAMP-Activated Protein KinasesAmyloid beta-PeptidesCarotenoidsStk11 protein, mousetrans-sodium crocetinateVitamin AAlzheimer diseaseAMPK pathwayamyloid-βautophagyLKB1

Identifiers

PMID33404280
PMCPMC8632093
OpenAlexW3118761073

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.